PGR and breast cancer: A multinomial logistic regression model was trained on 691 complete cases using only clinical predictors (estrogen receptor [ER], progesterone receptor [PR], HER2 status, tumor stage, and age) to predict PAM50 molecular subtypes, a genomic classification system originally developed by Parker et al, and widely used in breast cancer subtyping.